ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,784,273 | +45.0% | 154,149 | +15.0% | 1.17% | +26.2% |
Q2 2023 | $52,262,793 | +74.3% | 134,100 | +66.6% | 0.92% | +59.8% |
Q1 2023 | $29,992,690 | +217.0% | 80,500 | +168.3% | 0.58% | +407.9% |
Q1 2022 | $9,460,000 | -47.6% | 30,000 | -50.0% | 0.11% | -51.7% |
Q2 2021 | $18,060,000 | +145.6% | 60,000 | +140.0% | 0.24% | +40.5% |
Q4 2020 | $7,353,000 | -30.0% | 25,000 | -37.5% | 0.17% | -31.7% |
Q3 2020 | $10,504,000 | +17.2% | 40,000 | +0.5% | 0.25% | -17.7% |
Q2 2020 | $8,965,000 | – | 39,800 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |